Search Results - "England, Ross"

Refine Results
  1. 1

    Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms by Kako, Farah, Gabunia, Khatuna, Ray, Mitali, Kelemen, Sheri E, England, Ross N, Kako, Bashar, Scalia, Rosario G, Autieri, Michael V

    “…Neovascularization and inflammation are independent biological processes but are linked in response to injury. The role of inflammation-dampening cytokines in…”
    Get more information
    Journal Article
  2. 2

    Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model by England, Ross N., Drapeau, Elizabeth M., Alameh, Mohamad-Gabriel, Hosseinzadeh, Reihaneh, Weissman, Drew, Hensley, Scott E.

    Published in npj vaccines (18-06-2024)
    “…Maternal antibodies (matAbs) protect against a myriad of pathogens early in life; however, these antibodies can also inhibit de novo immune responses against…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC by Gabunia, Khatuna, Herman, Allison, Ray, Mitali, Kelemen, Sheri, England, Ross N, Cadena, Raul DeLa, Foster, William J, Elliott, Katherine J, Eguchi, Satoru, Autieri, Michael V

    “…Abstract The transformation of vascular smooth muscle cells [VSMC] into foam cells leading to increased plaque size and decreased stability is a key, yet…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Attenuation of Experimental Atherosclerosis by Interleukin-19 by Ellison, Stephen, Gabunia, Khatuna, Kelemen, Sheri E., England, Ross N., Scalia, Rosario, Richards, James M., Orr, Wayne, Traylor, James G., Rogers, Thomas, Cornwell, William, Berglund, Lisa M., Goncalves, Isabel, Gomez, Maria F., Autieri, Michael V.

    “…OBJECTIVE—Interleukin-19 (IL-19) is a putative Th2, anti-inflammatory interleukin. Its expression and potential role in atherogenesis are unknown. IL-19 is not…”
    Get full text
    Journal Article
  7. 7

    Interleukin-19 decreases leukocyte-endothelial cell interactions by reduction in endothelial cell adhesion molecule mRNA stability by England, Ross N, Preston, Kyle J, Scalia, Rosario, Autieri, Michael V

    “…Vascular endothelial cell (EC) inflammation is a key event in the pathogenesis of multiple vascular diseases. We tested the hypothesis that interleukin-19…”
    Get more information
    Journal Article
  8. 8

    IL-19 Reduces Ligation-Mediated Neointimal Hyperplasia by Reducing Vascular Smooth Muscle Cell Activation by Ellison, Stephen, Gabunia, Khatuna, Richards, James M, Kelemen, Sheri E, England, Ross N, Rudic, Dan, Azuma, Yasu-Taka, Munroy, M. Alexandra, Eguchi, Satoru, Autieri, Michael V

    Published in The American journal of pathology (01-07-2014)
    “…We tested the hypothesis that IL-19, a putative member of the type 2 helper T-cell family of anti-inflammatory interleukins, can attenuate intimal hyperplasia…”
    Get full text
    Journal Article
  9. 9

    Anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility by Gabunia, Khatuna, Jain, Surbhi, England, Ross N, Autieri, Michael V

    “…Vascular smooth muscle cell (VSMC) migration is an important cellular event in multiple vascular diseases, including atherosclerosis, restenosis, and…”
    Get more information
    Journal Article
  10. 10

    Increased atherosclerosis and vascular smooth muscle cell activation in AIF-1 transgenic mice fed a high-fat diet by Sommerville, Laura J, Kelemen, Sheri E, Ellison, Stephen P, England, Ross N, Autieri, Michael V

    Published in Atherosclerosis (01-01-2012)
    “…Abstract Allograft inflammatory factor-1 (AIF-1) is a cytoplasmic, scaffold signal transduction protein constitutively expressed in inflammatory cells, but…”
    Get full text
    Journal Article
  11. 11

    Anti-Inflammatory Effects of Interleukin-19 in Vascular Disease by England, Ross N., Autieri, Michael V.

    Published in International journal of inflammation (01-01-2012)
    “…Despite aggressive dietary modification, lipid-lowering medications, and other interventional medical therapy, vascular disease continues to be a leading cause…”
    Get full text
    Journal Article
  12. 12
  13. 13

    2342. Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model by England, Ross N, Drapeau, Elizabeth, Hosseinzadeh, Reihaneh, Weissman, Drew, Hensley, Scott

    Published in Open forum infectious diseases (27-11-2023)
    “…Abstract Background Maternal antibodies (matAbs) protect against a myriad of pathogens early in life; however, these antibodies can also inhibit de novo immune…”
    Get full text
    Journal Article
  14. 14

    Abstract 47: FXR1 Regulates Inflammatory MRNA Stability and VSMC Proliferation by Modulation of HuR Activity by Herman, Allison, England, Ross, Haines, Dale, Kelemen, Sheri, Ray, Mitali, Autieri, Michael V

    “…Abstract only Vascular smooth muscle cells (VSMC) play a critical role in the etiology and progression of many vascular diseases including atherosclerosis and…”
    Get full text
    Journal Article
  15. 15

    Abstract 404: Induction of MiR133a Expression By IL-19 Targets LDLRAP1 and Reduces Oxidized LDL Uptake in VSMC by Gabunia, Khatuna, Herman, Allison, Ray, Mitali, Kelemen, Sheri, England, Ross, DeLaCadena, Raul, Foster, William, Elliott, Katherine, Eguchi, Satoru, Autieri, Michael

    “…Abstract only Introduction: The transformation of vascular smooth muscle cells (VSMC) into foam cells leading to increased plaque size and decreased stability…”
    Get full text
    Journal Article
  16. 16

    Human Blood Plasma Shapes Distinct Neonatal TLR-Mediated Dendritic Cell Activation via Expression of the MicroRNA Let-7g by England, Ross, Pak, Jensen, Liu, Mark, Rao, Shun, Ozonoff, Al, Levy, Ofer, van Haren, Simon D

    Published in ImmunoHorizons (30-04-2021)
    “…The newborn innate immune system is characterized as functionally distinct, resulting in impaired proinflammatory responses to many stimuli and a bias toward…”
    Get full text
    Journal Article
  17. 17

    Identifying Mechanisms of Interleukin‐19‐Mediated HuR‐Dependent Reduction in Vascular Cell mRNA Stability by England, Ross Nevin, Kelemen, Sheri, Ellison, Stephen, Autieri, Michael

    Published in The FASEB journal (01-04-2013)
    “…Abstract only IL‐19 reduces TNF‐α‐driven mRNA abundance and protein abundance of intercellular adhesion molecule‐1 (ICAM‐1) and vascular cell adhesion…”
    Get full text
    Journal Article
  18. 18

    The Anti‐Inflammatory Cytokine Interleukin‐19 Inhibits Smooth Muscle Cell Migration and Activation of Cytoskeletal Regulators of VSMC Motility by Gabunia, Khatuna, Jain, Surbhi, England, Ross, Autieri, Michael

    Published in The FASEB journal (01-04-2011)
    “…Vascular Smooth Muscle Cell (VSMC) migration is an important cellular event in multiple vascular diseases. We tested the hypothesis that an anti‐inflammatory,…”
    Get full text
    Journal Article
  19. 19

    Abstract 79: Interleukin-19 Reduces Leukocyte-Endothelial Cell Interactions by England, Ross N, Kelemen, Sheri E, Preston, Kyle J, Ellison, Stephen P, Scalia, Rosario, Autieri, Michael V

    “…Abstract only Introduction Vascular endothelial cells (EC) actively participate in the pathogenesis of atherosclerosis by increasing expression of cell…”
    Get full text
    Journal Article
  20. 20

    Attenuation of Experimental Atherosclerosis by Interleukin‐19 by Ellison, Stephen, Gabunia, Khatuna, Richards, James, Kelemen, Sheri E, England, Ross N, Scalia, Rosario, Orr, A. Wayne, Berglund, Lisa M, Gomez, Maria F, Autieri, Michael V

    Published in The FASEB journal (01-04-2013)
    “…Abstract only Interleukin‐19 (IL‐19) is a Th2, anti‐inflammatory interleukin. IL‐19 is expressed in several cell types in human atherosclerotic plaque. We…”
    Get full text
    Journal Article